MCID: DLS001
MIFTS: 41

Delusional Disorder malady

Category: Mental diseases

Aliases & Classifications for Delusional Disorder

About this section

Aliases & Descriptions for Delusional Disorder:

Name: Delusional Disorder 11 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:778
ICD1030 F22, F22.0
ICD9CM32 297.1
SNOMED-CT62 192330005, 48500005
MeSH39 D012563
NCIt45 C94379

Summaries for Delusional Disorder

About this section
Disease Ontology:11 A psychotic disorder that involves an uncommon psychiatric condition in which patients present with circumscribed symptoms of non-bizarre delusions, but with the absence of prominent hallucinations and no thought disorder, mood disorder, or significant flattening effect.

MalaCards based summary: Delusional Disorder is related to schizophrenia and personality disorder. An important gene associated with Delusional Disorder is DRD2 (Dopamine Receptor D2), and among its related pathways are DARPP-32 Phosphorylation and GPCRs, Other. Affiliated tissues include eye, pituitary and brain, and related mouse phenotype Decreased shRNA abundance (Z-score < -2).

Wikipedia:71 Delusional disorder is a mental illness in which the patient presents with delusions, but with no... more...

Related Diseases for Delusional Disorder

About this section

Diseases related to Delusional Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 67)
idRelated DiseaseScoreTop Affiliating Genes
1schizophrenia30.7DRD2, DRD3, DRD4, TH
2personality disorder29.4DRD2, DRD3, DRD4
3capgras syndrome11.1
4paranoid schizophrenia10.5
5teratoma with malignant transformation10.1DRD2, DRD3
6ischemic neuropathy10.1DRD2, DRD3
7usher syndrome10.1DRD2, DRD3
8transmitted_by10.1DRD2, DRD3
9hypoglycemia10.0DRD2, DRD3
1018p deletion syndrome10.0DRD2, DRD4
11colorectal adenocarcinoma10.0DRD2, DRD4
12rectosigmoid junction neoplasm10.0DRD2, DRD4
13suppurative periapical periodontitis10.0DRD2, DRD3, TH
14cavernous hemangioma10.0DRD2, DRD3, TH
15autism 1910.0DRD2, TH
16hemochromatosis, type 2a10.0DRD2, DRD3, TH
17brain glioblastoma multiforme9.9DRD2, DRD3, TH
18body dysmorphic disorder9.9
19carotid stenosis9.9DRD2, DRD4
20alzheimer disease 179.9DRD3, DRD4
21mastitis9.9DRD4, HLA-A
22aortic valve disease 29.9DRD2, DRD4
23intracranial aneurysm9.9DRD2, DRD3, DRD4
24pyromania9.9DRD2, DRD3, DRD4
25c8 deficiency, type ii9.9DRD2, DRD3, DRD4
26cecal benign neoplasm9.9DRD2, DRD3, DRD4
27mucinous adenocarcinoma9.8DRD2, DRD3, DRD4
28alopecia9.8DRD2, DRD3, DRD4
29hypereosinophilic syndrome9.8DRD2, DRD3, DRD4
30retinoblastoma9.8DRD2, DRD3, DRD4
31microcephaly 13, primary, autosomal recessive9.8DRD2, DRD3, DRD4
32preeclampsia/eclampsia 59.8DRD2, DRD3, DRD4
33benign epilepsy with centrotemporal spikes9.8DRD2, DRD4, TH
34paraphilia disorder9.8DRD2, DRD3, DRD4
35schizotypal personality disorder9.8
36early-onset schizophrenia9.8
37anorexia nervosa9.8
38dementia9.8
39hepatitis d9.8DRD2, DRD4
40cytomegalic congenital adrenal hypoplasia9.7DRD2, DRD3, DRD4, TH
41ellis-van creveld syndrome9.6DRD2, DRD3, DRD4, TH
42trimethylaminuria9.6
43alcohol dependence9.6
44hyperprolactinemia9.6
45phenylketonuria9.6
46alcohol abuse9.6
47bipolar disorder9.6
48charcot-marie-tooth disease9.6
49hydrocephalus9.6
50sleep apnea9.6

Comorbidity relations with Delusional Disorder via Phenotypic Disease Network (PDN):


Parkinson Disease, Late-OnsetAlzheimer Disease
Deficiency AnemiaParanoid Personality Disorder
Schizophreniform DisorderDysthymic Disorder
Paranoid SchizophreniaAcute Cystitis
HypothyroidismAnxiety Disorder

Graphical network of the top 20 diseases related to Delusional Disorder:



Diseases related to delusional disorder

Symptoms & Phenotypes for Delusional Disorder

About this section

GenomeRNAi Phenotypes related to Delusional Disorder according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-849.2DRD3, DRD4

Drugs & Therapeutics for Delusional Disorder

About this section

Drugs for Delusional Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 137)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DonepezilapprovedPhase 4, Phase 3286120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
2
Risperidoneapproved, investigationalPhase 4, Phase 3, Phase 2492106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
3
Olanzapineapproved, investigationalPhase 4, Phase 3, Phase 2399132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
 
LY-170053
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
4
DopamineapprovedPhase 4, Phase 3, Phase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
5
CitalopramapprovedPhase 4, Phase 251259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
6
Carbamazepineapproved, investigationalPhase 4132298-46-42554
Synonyms:
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
298-46-4
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
BIDD:GT0479
BIM-0050280.0001
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
Bio-0751
Bipotrol
Biston
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
CARBAMAZEPINE, U.S.P.
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
CID2554
CPD001227191
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
Carbamazepine (JP15/USP/INN)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamazépine
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
ChemDiv1_018966
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
EU-0100292
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
Equetro (TN)
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
 
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Karbamazepin
LS-60362
Lexin
Lopac-C-4024
Lopac0_000292
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NINDS_000388
NSC 169864
NSC169864
Neurotol
Neurotop retard
Novo-Carbamaz
Nu-Carbamazepine
Oprea1_790775
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Prestwick_104
S1693_Selleck
SAM002264603
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
SPECTRUM1500159
STK177357
Sirtal
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Spectrum_000096
Stazepin
Stazepine
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
benzo[b][1]benzazepine-11-carboxamide
carbamazepine
carbamazepine (Tegretol)
nchem.859-comp7
7PiracetamapprovedPhase 41757491-74-9
8
NicergolineapprovedPhase 4227848-84-634040
Synonyms:
(+)-10-Methoxy-1,6-dimethylergoline-8-beta-methanol 5-bromonicotinate
1-Methyl-lumilysergol 8-(5-bromonicotinate) 10-methyl ether
10-Methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat)
10-Methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat) [German]
10-Methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyrindinecarboxylate (ester)
10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate
10-Methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate (ester)
27848-84-6
5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester
8-beta-((5-Bromonicotinoyloxy)methyl)-1,6-dimethyl-10-alpha-methoxyergoline
AC1L1QT0
AKOS005067888
BPBio1_000280
BRD-K76810206-001-05-7
BRN 4828393
BSPBio_000254
BSPBio_003533
Bio-0069
C24H26BrN3O3
CID34040
D01290
DB00699
DivK1c_000124
EINECS 248-694-6
Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester)
Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester)
Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, (8beta)-, 5-bromo-3-pyridinecarboxylate (ester)
Ergoline-8beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester)
Ergoline-8beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester) (8CI)
F.I. 6714
FI 6714
HMS1568M16
HMS1923O09
HMS2089I03
HMS2092F07
HMS500G06
I06-1875
IDI1_000124
KBio1_000124
KBio2_001850
KBio2_004418
 
KBio2_006986
KBio3_002787
KBioGR_000800
KBioSS_001850
LS-64447
MNE
MolPort-002-513-778
N7889_FLUKA
N7889_SIGMA
NCGC00024678-02
NCGC00024678-03
NINDS_000124
NSC 150531
Nargoline
Nicergolin
Nicergolin [German]
Nicergolina
Nicergolina [DCIT]
Nicergoline
Nicergoline (JP15/USAN/INN)
Nicergoline [USAN:BAN:INN:JAN]
Nicergolinum
Nicergolinum [INN-Latin]
Nicotergoline
Nimergoline
Nimergoline base
Prestwick0_000147
Prestwick1_000147
Prestwick2_000147
Prestwick3_000147
QTL1_000060
RP 19651
SPBio_001488
SPBio_002193
SPECTRUM1501133
Sermion
Sermion (TN)
Spectrum2_001414
Spectrum3_001933
Spectrum4_000440
Spectrum5_001352
Spectrum_001370
nicergoline
9
GalantamineapprovedPhase 4106357-70-09651, 908828, 9651
Synonyms:
(-)-Galanthamine
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol
1551-02-6
1953-04-4
1dx6
1qti
357-70-0
4-27-00-02184 (Beilstein Handbook Reference)
736-79-8
AC-20240
AC1L1TIM
BIDD:GT0517
BPBio1_000480
BRD-K49481516-004-03-5
BRD-K49481516-004-04-3
BRN 0093736
BSPBio_000436
BSPBio_003416
C08526
CHEBI:42944
CHEMBL659
CID9651
D04292
DivK1c_000590
GNT
Galantamin
Galantamina
Galantamina [INN-Spanish]
Galantamine
Galantamine (USAN/INN)
Galantamine [USAN:INN]
Galantaminum
Galantaminum [INN-Latin]
Galanthamine
Galanthamine hydrobromide
Galanthaminum
 
HMS2089H03
HSDB 7361
IDI1_000590
InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
Jilkon
KBio1_000590
KBio2_001751
KBio2_004319
KBio2_006887
KBio3_002636
KBioGR_001417
KBioSS_001751
LS-71039
Lycoremin
Lycoremine
MolPort-002-521-885
NCGC00024731-02
NINDS_000590
NSC 100058
Prestwick0_000588
Prestwick1_000588
Prestwick2_000588
Prestwick3_000588
Probes1_000055
Probes2_000395
Razadyne ER
Reminyl
Reminyl (TN)
SDCCGMLS-0066737.P001
SMP1_000131
SPBio_002655
STOCK1N-46108
Spectrum3_001738
Spectrum4_000839
Spectrum5_001673
Spectrum_001271
UNII-0D3Q044KCA
galanthamine
10
Armodafinilapproved, investigationalPhase 4197112111-43-0
Synonyms:
 
(–)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
R-modafinil
11
OxcarbazepineapprovedPhase 45628721-07-534312
Synonyms:
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
28721-07-5
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
AB1004555
AC-3483
AC1L1RCU
AC1Q6NA8
BIDD:GT0078
BSPBio_003457
Bio-0527
C036006
C07492
CHEMBL1068
CID34312
CPD000048684
D00533
DB00776
Desitin brand of oxcarbazepine
EINECS 249-188-8
Epilexter
Epliga
GP 47680
GP-47680
HMS1922H17
HMS2051O04
HMS2090F13
HMS2093E10
HSDB 7524
I06-0072
KBio2_002155
KBio2_004723
KBio2_007291
KBio3_002677
KBioGR_001248
KBioSS_002155
 
KIN-493
LS-60365
MLS000084586
MLS000759520
MLS001201742
MolPort-001-685-316
NCGC00065934-02
NCGC00065934-03
NCGC00065934-04
Novartis brand of oxcarbazepine
O0363
O3764_SIGMA
OCBZ
OXCARBAZEPINE
Oxacarbazepine
Oxcarbamazepine
Oxcarbazepime
Oxcarbazepina
Oxcarbazepina [INN-Spanish]
Oxcarbazepine
Oxcarbazepine (USAN/INN)
Oxcarbazepine [INN]
Oxcarbazepinum
Oxcarbazepinum [INN-Latin]
S1391_Selleck
SAM001246754
SMR000048684
SPBio_000345
SPECTRUM1504243
SPN-804
STK594696
Spectrum2_000483
Spectrum3_001669
Spectrum4_000634
Spectrum5_001869
Spectrum_001675
Timox
Trileptal
Trileptal (TN)
UNII-VZI5B1W380
ZINC00004724
oxcarbazepine
12
Modafinilapproved, investigationalPhase 419768693-11-84236
Synonyms:
2-((diphenylmethyl)sulfinyl)acetamide
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
 
Modafinilo [Spanish]
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
13
ZiprasidoneapprovedPhase 4145146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
14
CycloserineapprovedPhase 4, Phase 310868-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
15
Sulfamethazineapproved, vet_approvedPhase 410757-68-15327
Synonyms:
(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin
(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin
(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin [German]
00189_FLUKA
2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-Sulfanilamido-4,6-dimethylpyrimidine
4,6-Dimethyl-2-sulfanilamidopyrimidine
4,6-Dimethylsulfadiazine
4-Amino-N- [4,6-dimethyl-2-pyrimidinyl]- benzenesulfonamide
4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide
4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide
4-Amino-N-(4,6-dimethyl-2-pyrimidyl)benzenesulfonamide
4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide
4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
46802_FLUKA
46802_RIEDEL
5-25-10-00250 (Beilstein Handbook Reference)
57-68-1
6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin
6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin [German]
A-502
AC-16126
AC1L1K3W
AC1Q2ID9
AI3-26817
AKOS000119894
ARONIS018080
Azolmetazin
BIDD:PXR0093
BN 2409
BPBio1_000936
BRD-K11640013-001-02-6
BRD-K11640013-236-03-6
BRN 0261304
BSPBio_000850
BSPBio_003260
Bio-0716
CBDivE_012932
CCRIS 3701
CHEBI:102265
CHEMBL446
CID5327
Calfspan Tablets
Cremomethazine
D013418
D02436
DB01582
Diazil
Diazil (the sulfanilamide)
Dimezathine
Dimidin-R
DivK1c_000293
EINECS 200-346-4
HC210279
HMS1921A17
HMS2092I19
HMS500O15
HSDB 4157
Hava-Span
IDI1_000293
Intradine
KBio1_000293
KBio2_001470
KBio2_004038
KBio2_006606
KBio3_002480
KBioGR_000747
KBioSS_001470
Kelametazine
LS-232
MLS000069711
MLS000103403
MLS001077331
MLS002454449
Mermeth
MolPort-000-887-465
N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N(Sup1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(Sup1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N(sup 1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(sup 1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
 
N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
NCGC00018243-01
NCGC00021490-03
NCGC00021490-04
NCGC00021490-05
NCGC00021490-06
NCI-C56600
NCIOpen2_003489
NINDS_000293
NSC 67457
NSC67457
NSC683529
Neasina
Neazina
Oprea1_142608
Oprea1_677935
Pirmazin
Prestwick0_000775
Prestwick1_000775
Prestwick2_000775
Prestwick3_000775
Primazin
S0586
S6256_SIGMA
SMR000017409
SMZ
SPBio_001441
SPBio_002789
SPECTRUM1500548
STK097514
Sa III
Solfadimidina
Solfadimidina [DCIT]
Spanbolet
Spectrum2_001321
Spectrum3_001700
Spectrum4_000344
Spectrum5_001270
Spectrum_000990
Sulfa-Isodimerazine
SulfaSURE SR Bolus
Sulfadimerazine
Sulfadimesin
Sulfadimesine
Sulfadimethyldiazine
Sulfadimethylpyrimidine
Sulfadimezin
Sulfadimezine
Sulfadimezinum
Sulfadimidin
Sulfadimidina
Sulfadimidina [INN-Spanish]
Sulfadimidine
Sulfadimidine (INN)
Sulfadimidine [INN:BAN]
Sulfadimidine solution
Sulfadimidinum
Sulfadimidinum [INN-Latin]
Sulfadine
Sulfametazina
Sulfametazina [Italian]
Sulfametazyny
Sulfametazyny [Polish]
Sulfamethazine (USP)
Sulfamethazine solution
Sulfamethiazine
Sulfamezathine
Sulfamezathine (TN)
Sulfodimesin
Sulfodimezine
Sulka S Boluses
Sulphadimethylpyrimidine
Sulphadimidine
Sulphamethasine
Sulphamethazine
Sulphamezathine
Sulphamidine
Sulphodimezine
Superseptil
Superseptyl
UNII-48U51W007F
Vertolan
WLN: T6N CNJ BMSWR DZ& D1 F1
ZINC00057494
[(4-Aminophenyl)sulfonyl](4,6-dimethylpyrimidin-2-yl)amine
n(sup1)-(2,6-Dimethylpyrimid-4-yl)sulfanilamide
sulfamethazine
16
Acetylcysteineapproved, investigationalPhase 4330616-91-112035
Synonyms:
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
Fluprowit
 
L-Acetylcysteine
L-acetylcysteine
L-α-acetamido-β-mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetyl-L-(+)-cysteine
N-acetyl-L-cysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
17
AcetaminophenapprovedPhase 41026103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
18
Melatoninapproved, nutraceutical, vet_approvedPhase 426873-31-4896
Synonyms:
0E2B08C1-B325-45B1-8939-6F9081EFDFA4
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-22-12-00042 (Beilstein Handbook Reference)
5-Methoxy-N-acetyltryptamine
5-methoxy-N-acetyltryptamine
73-31-4
A4039/0172195
AB00053279
AC1L1A9Q
AC1Q4F1W
AC1Q4F1X
AKOS000276269
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI)
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
BAS 01281092
BIDD:ER0618
BPBio1_000590
BRD-K97530723-001-07-6
BRN 0205542
BSPBio_000536
BSPBio_003006
Bio-0635
C01598
CAS-73-31-4
CCRIS 3472
CHEBI:16796
CHEMBL45
CID896
ChemDiv2_003916
Circadin
D008550
D08170
DB01065
DB08189
DivK1c_000353
EINECS 200-797-7
EU-0100787
HMS1380B22
HMS1569K18
HMS1921E04
HMS2089F09
HMS501B15
HSCI1_000400
HSDB 7509
I05-0076
I10-0345
IDI1_000353
IDI1_002631
IN1244
KBio1_000353
KBio2_000665
KBio2_003233
KBio2_005801
KBio3_002226
KBioGR_000591
KBioSS_000665
L001261
LS-1623
Lopac-M-5250
Lopac0_000787
M 5250
M-1200
M-1250
M1105
M5250_SIGMA
ML1
MLS000859594
MLS001055382
MLS001240204
MT6
Mela-T
Melapure
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonin (synth.) standard-grade
 
Melatonin (synth.) ultra-pure
Melatonina
Melatonina (TN)
Melatonine
Melovine
MolPort-000-737-883
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine Melatonine
N-Acetyl-5-methoxytryptamine
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-acetyl-5-methoxy-tryptamine
NCGC00015680-01
NCGC00015680-02
NCGC00015680-03
NCGC00015680-06
NCGC00015680-13
NCGC00090727-01
NCGC00090727-02
NCGC00090727-03
NCGC00090727-04
NCGC00090727-05
NCGC00090727-06
NCGC00090727-07
NCGC00090727-08
NCGC00090727-09
NCI60_004378
NINDS_000353
NMR/14327425
NSC 113928
NSC113928
NSC56423
Nature'S Harmony
Night Rest
Oprea1_104553
Oprea1_814234
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Pineal Hormone
Posidorm
Prestwick0_000458
Prestwick1_000458
Prestwick2_000458
Prestwick3_000458
Prestwick_312
Regulin
Revital Melatonin
Rx Balance
S1204_Selleck
SDCCGMLS-0065812.P001
SDCCGMLS-0065812.P002
SMP2_000309
SMR000326666
SPBio_001527
SPBio_002475
SPECTRUM1500690
STK386880
Sleep Right
Spectrum2_001344
Spectrum3_001393
Spectrum4_000066
Spectrum5_001745
Spectrum_000185
TNP00300
UNII-JL5DK93RCL
Vivitas
WLN: T56 BMJ D2MV1 GO1
ZINC00057060
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide
19Antipsychotic AgentsPhase 4, Phase 3, Phase 2, Early Phase 12401
20Cholinesterase InhibitorsPhase 4, Phase 3592
21Cholinergic AgentsPhase 4, Phase 33992
22Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 23521
23Anti-Infective AgentsPhase 4, Phase 3, Phase 1, Phase 222062
24Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 21587
25Anti-Bacterial AgentsPhase 4, Phase 3, Phase 1, Phase 211226
26Autonomic AgentsPhase 4, Phase 3, Phase 210150
27Nootropic AgentsPhase 4, Phase 3716
28Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16430
29Serotonin AgentsPhase 4, Phase 3, Phase 23156
30Serotonin AntagonistsPhase 4, Phase 3, Phase 21409
31Tranquilizing AgentsPhase 4, Phase 3, Phase 24265
32Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
33
SerotoninPhase 4, Phase 3, Phase 2362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
34Central Nervous System DepressantsPhase 4, Phase 3, Phase 213403
35Dopamine AgentsPhase 4, Phase 3, Phase 23836
36Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
37Dopamine AntagonistsPhase 4, Phase 3, Phase 21093
38Antibiotics, AntitubercularPhase 4, Phase 37180
39Paliperidone PalmitatePhase 4, Phase 3, Phase 2165
40Dopamine D2 Receptor AntagonistsPhase 4, Phase 3, Phase 2333
41Serotonin 5-HT2 Receptor AntagonistsPhase 4, Phase 3, Phase 2225
42Antitubercular AgentsPhase 4, Phase 31343
43Quetiapine FumaratePhase 4413111974-72-2
44Wakefulness-Promoting AgentsPhase 4193
45Renal AgentsPhase 4, Phase 3754
46AntioxidantsPhase 4, Phase 2, Phase 33050
47AntimetabolitesPhase 4, Phase 312054
48AnalgesicsPhase 4, Phase 1, Phase 211733
49Vasodilator AgentsPhase 43543
50Antidepressive AgentsPhase 4, Phase 3, Phase 22736

Interventional clinical trials:

(show top 50)    (show all 108)
idNameStatusNCT IDPhase
1A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
2The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedNCT00154323Phase 4
3An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCompletedNCT01855074Phase 4
4An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCompletedNCT00526877Phase 4
5An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00992407Phase 4
6Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily RoutineCompletedNCT01009476Phase 4
7A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe DepressionCompletedNCT01814085Phase 4
8An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaCompletedNCT00269919Phase 4
9A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCompletedNCT00378092Phase 4
10Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With SchizophreniaCompletedNCT01726335Phase 4
11"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"CompletedNCT01023672Phase 4
12A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaCompletedNCT01577160Phase 4
13PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute SchizophreniaCompletedNCT00761189Phase 4
14Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia ParticipantsCompletedNCT01387542Phase 4
15Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic RemissionCompletedNCT00761579Phase 4
16Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic ParticipantsCompletedNCT00784238Phase 4
17A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With SchizophreniaCompletedNCT00915512Phase 4
18An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT00757705Phase 4
19A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With RisperidoneCompletedNCT01010776Phase 4
20Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 YearsCompletedNCT01362439Phase 4
21Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for SchizophreniaCompletedNCT00742079Phase 4
22D-Cycloserine Augmentation of Cognitive Behavioral Therapy for DelusionsRecruitingNCT01981759Phase 4
23Integrated Care in Psychotic Disorders With Severe Mental IllnessRecruitingNCT01888627Phase 4
24Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteineRecruitingNCT02505477Phase 4
25Melatonin for Delirium ProphylaxisNot yet recruitingNCT02282241Phase 4
26Schizophrenic Patients in Integrated CareTerminatedNCT00681629Phase 4
27An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of SchizophreniaTerminatedNCT01894984Phase 4
28A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationTerminatedNCT00256997Phase 4
29Observational Study Of Donepezil In Routine Clinical PracticeTerminatedNCT00843115Phase 4
30Trial of Cognitive Behavioral Therapy for SchizophreniaUnknown statusNCT00300651Phase 3
31Donepezil Treatment of Psychotic Symptoms in Dementia PatientsUnknown statusNCT00190021Phase 3
32Study of Pharmacotherapy of Psychotic DepressionCompletedNCT00056472Phase 3
33Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT01888107Phase 3
34A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00130676Phase 3
35A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128479Phase 3
36An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128505Phase 3
37A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00208156Phase 3
38An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00146523Phase 3
39A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00249158Phase 3
40A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With SchizophreniaCompletedNCT00604279Phase 3
41Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT01662648Phase 3
42An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With SchizophreniaCompletedNCT01009047Phase 3
43An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With SchizophreniaCompletedNCT00566631Phase 3
44An Efficacy and Safety Study of Paliperidone Palmitate in Participants With SchizophreniaCompletedNCT01299389Phase 3
45A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With SchizophreniaCompletedNCT01541371Phase 3
46Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and AntioxidantsCompletedNCT00419146Phase 2, Phase 3
47Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3
48An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaActive, not recruitingNCT00460512Phase 3
49A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTerminatedNCT00287742Phase 3
50A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's DiseaseTerminatedNCT00912288Phase 3

Search NIH Clinical Center for Delusional Disorder

Genetic Tests for Delusional Disorder

About this section

Anatomical Context for Delusional Disorder

About this section

MalaCards organs/tissues related to Delusional Disorder:

36
Eye, Pituitary, Brain, Liver

Publications for Delusional Disorder

About this section

Articles related to Delusional Disorder:

(show top 50)    (show all 175)
idTitleAuthorsYear
1
What is the Evidence for Treating Delusional Disorder? (27712246)
2016
2
Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder. (27335526)
2016
3
A Systematic Review on the Pharmacological Treatment of Delusional Disorder. (27811554)
2016
4
Characteristics and clinical correlates of dimensions of delusional experience in schizophrenia and delusional disorder. (27261418)
2016
5
Clinical Presentation and Course of Persistent Delusional Disorder: Data From a Tertiary Care Center in India. (27247844)
2016
6
Delusional disorder and schizophrenia: a comparative study across multiple domains. (27468631)
2016
7
Folie a deux and delusional disorder by proxy: an atypical presentation. (27245561)
2016
8
Structural and functional brain changes in delusional disorder. (26382955)
2016
9
Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015). (26690961)
2016
10
Antipsychotic response in delusional disorder and schizophrenia: a prospective cohort study. (27388104)
2016
11
Unexpected subthreshold autism spectrum in a 25-year-old male stalker hospitalized for delusional disorder: a case report. (26031384)
2015
12
A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder. (26585220)
2015
13
Therapeutic approach to delusional disorder based on psychopathological complexity: proposal for a decision model. (25679132)
2015
14
Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015) - a reply. (26691196)
2015
15
Treatments for delusional disorder. (25997589)
2015
16
Delusional disorder and schizophrenia: a comparison of the neurocognitive and clinical characteristics in first-episode patients. (26036591)
2015
17
Treatments for Delusional Disorder. (26209547)
2015
18
The prevalence of delusional disorder in prison. (25770283)
2015
19
Normal pressure hydrocephalus presenting as delusional disorder. (26257493)
2015
20
Paranoid delusional disorder follows social anxiety disorder in a long-term case series: evolutionary perspective. (26034873)
2015
21
Delusional Disorder over the Reproductive Life Span: The Potential Influence of Menopause on the Clinical Course. (26600949)
2015
22
Phenotypic cognitive impairment in late-onset delusional disorder. (24524668)
2014
23
Delusional Disorder as a Partial Psychosis. (24421383)
2014
24
Aripiprazole in difficult-to-treat delusional disorder with co-morbid epilepsy. (24779650)
2014
25
Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder. (25478273)
2014
26
Delusional disorder: no gender differences in age at onset, suicidal ideation, or suicidal behavior. (24554277)
2014
27
Delusional disorder: an unusual presentation. (25336783)
2014
28
Russell's sign in persistent delusional disorder: a case report. (25093783)
2014
29
Sexual Feelings Toward the Therapist Among Patients with Borderline Personality Disorder: A Case of Erotomanic Delusional Disorder. (25391585)
2014
30
Psy-feld: An Innovative Didactic Using the TV Show Seinfeld to Teach Delusional Disorder Subtypes. (25410045)
2014
31
Suicidal ideation and suicidal behaviour in delusional disorder: a clinical overview. (24829903)
2014
32
Atypical delusional content in a case of persistent delusional disorder: freud revisited. (25336780)
2014
33
Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): a report of two cases. (23595526)
2013
34
Low-dose quetiapine for the treatment of delusional disorder in a patient with Von Hippel-Lindau disease. (24026746)
2013
35
Delusional disorder, somatic type: olfactory reference syndrome in a patient with delusional trimethylaminuria. (23719328)
2013
36
Reproductive variables and gynaecological service use in delusional disorder outpatients. (24378254)
2013
37
Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. (24272318)
2013
38
Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region. (23909967)
2013
39
Deficits in executive and memory processes in delusional disorder: a case-control study. (23844005)
2013
40
Empirical redefinition of delusional disorder and its phenomenology: the DELIREMP study. (23021895)
2013
41
Delayed-onset post-stroke delusional disorder: a case report. (23619082)
2013
42
A descriptive retrospective study of the treatment and outpatient service use in a clinical group of delusional disorder patients. (23490496)
2013
43
Delusional disorder and oncology: review of the literature and case report. (24066407)
2013
44
Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature. (23771191)
2013
45
Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder. (23993136)
2013
46
The clinical and sociodemographic profile of persistent delusional disorder. (22441422)
2012
47
Delusional disorders--are they simply paranoid schizophrenia? (21078814)
2012
48
Imprisonment, alcohol dependence and risk of delusional disorder: a cross-sectional study. (22608012)
2012
49
Clinical course and personality in reactive, compared with nonreactive, delusional disorder. (22480586)
2012
50
Neuropsychological research in delusional disorder: a comprehensive review. (22269940)
2012

Variations for Delusional Disorder

About this section

Expression for genes affiliated with Delusional Disorder

About this section
Search GEO for disease gene expression data for Delusional Disorder.

Pathways for genes affiliated with Delusional Disorder

About this section

GO Terms for genes affiliated with Delusional Disorder

About this section

Cellular components related to Delusional Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endocytic vesicleGO:003013910.3DRD2, DRD3
2integral component of plasma membraneGO:00058878.2DRD2, DRD3, DRD4, HLA-A

Biological processes related to Delusional Disorder according to GeneCards Suite gene sharing:

(show all 38)
idNameGO IDScoreTop Affiliating Genes
1acid secretionGO:004671710.3DRD2, DRD3
2circadian regulation of gene expressionGO:003292210.3DRD2, DRD3
3G-protein coupled receptor internalizationGO:000203110.3DRD2, DRD3
4negative regulation of blood pressureGO:004577610.3DRD2, DRD3
5negative regulation of dopamine receptor signaling pathwayGO:006016010.3DRD2, DRD3
6negative regulation of protein kinase B signalingGO:005189810.3DRD2, DRD3
7positive regulation of cytokinesisGO:003246710.3DRD2, DRD3
8positive regulation of renal sodium excretionGO:003581510.3DRD2, DRD3
9prepulse inhibitionGO:006013410.3DRD2, DRD3
10regulation of cAMP metabolic processGO:003081410.3DRD2, DRD3
11regulation of dopamine secretionGO:001405910.3DRD2, DRD3
12regulation of dopamine uptake involved in synaptic transmissionGO:005158410.3DRD2, DRD3
13regulation of locomotion involved in locomotory behaviorGO:009032510.3DRD2, DRD3
14response to cocaineGO:004222010.3DRD2, DRD3
15pigmentationGO:004347310.2DRD2, TH
16learningGO:000761210.2DRD3, TH
17response to morphineGO:004327810.2DRD2, DRD3
18response to light stimulusGO:000941610.1DRD2, TH
19response to nicotineGO:003509410.1DRD2, TH
20behavioral response to ethanolGO:004814910.0DRD2, DRD4
21negative regulation of voltage-gated calcium channel activityGO:19013869.9DRD2, DRD4
22positive regulation of dopamine uptake involved in synaptic transmissionGO:00515869.9DRD2, DRD4
23cellular calcium ion homeostasisGO:00068749.9DRD3, DRD4
24locomotory behaviorGO:00076269.8DRD2, DRD3, TH
25response to ethanolGO:00454719.7DRD2, DRD3, TH
26visual learningGO:00085429.6DRD2, DRD3
27synaptic transmission, dopaminergicGO:00019639.5DRD2, DRD3, TH
28adenylate cyclase-inhibiting dopamine receptor signaling pathwayGO:00071959.5DRD2, DRD3, DRD4
29arachidonic acid secretionGO:00504829.5DRD2, DRD3, DRD4
30behavioral response to cocaineGO:00481489.5DRD2, DRD3, DRD4
31dopamine metabolic processGO:00424179.5DRD2, DRD3, DRD4
32dopamine receptor signaling pathwayGO:00072129.5DRD2, DRD3, DRD4
33negative regulation of adenylate cyclase activityGO:00071949.5DRD2, DRD3, DRD4
34negative regulation of protein secretionGO:00507099.5DRD2, DRD3, DRD4
35response to histamineGO:00347769.4DRD2, DRD3, DRD4
36response to drugGO:00424939.2DRD2, DRD3, PNP, TH
37social behaviorGO:00351769.2DRD3, DRD4, TH
38response to amphetamineGO:00019758.9DRD2, DRD3, DRD4, TH

Molecular functions related to Delusional Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dopamine neurotransmitter receptor activityGO:00049529.4DRD2, DRD3, DRD4
2dopamine neurotransmitter receptor activity, coupled via Gi/GoGO:00015919.4DRD2, DRD3, DRD4
3dopamine bindingGO:00352408.9DRD2, DRD3, DRD4, TH
4drug bindingGO:00081448.9DRD2, DRD3, DRD4, PNP
5signal transducer activityGO:00048718.8DRD2, DRD3, DRD4

Sources for Delusional Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet